King

FTC says King will sell painkiller to Actavis to resolve antitrust issue in Alpharma deal
Yahoo/AP
Tue, 12/30/08 - 08:37 am
Kadian
King
Alpharma
Actavis
King Pharmaceuticals Initiates Phase II Clinical Trial Evaluating T-62 as a Treatment for Neuropathic Pain
Business Wire
Sat, 12/27/08 - 11:23 am
King
T-62
neuropathic pain
King Pharmaceuticals extends tender offer for Alpharma
Marketwatch
Mon, 12/22/08 - 08:37 am
buyouts
Alpharma
King

Pages